POET Technologies Inc Dossier
|
SectorInformation Technology IndustrySemiconductors Beta (adjusted)0.89 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $7.64Price as of 1 Oct 2026 Data confidenceNot applicable Market Cap $1.3B Enterprise Value $1.3B Shares Outstanding 173.1M diluted Next Earnings Date12 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary POET Technologies is transitioning from a pre-revenue technology developer to a commercial-scale manufacturer of Photonic Integrated Circuits (PICs) and optical engines. The investment thesis is anchored by its proprietary Optical Interposer platform, which addresses critical bandwidth and power-efficiency bottlenecks in AI and hyperscale data center networks. While the company has historically experienced high volatility and significant net losses, its balance sheet is now heavily fortified with over $400 million in cash. Recent commercial milestones, including a strategic $50 million initial purchase order from Lumilens and partnerships with LITEON and Lessengers, signal strong market validation. The upcoming high-volume 800G production ramp in Q3 2026 and planned U.S. redomiciliation serve as near-term catalysts that could drive substantial valuation upside. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario The bear case reflects execution and customer concentration risks. The 800G production ramp in Malaysia faces technical or supply chain delays, pushing volume shipments into 2027. Customer qualification processes take longer than expected, or key partnerships fail to convert into recurring revenue, leading to continued heavy cash burn and potential future dilution. Base CaseCentral scenario The base case assumes POET successfully initiates its high-volume 800G production ramp in Malaysia during Q3 2026. The initial $50 million Lumilens order begins shipping on schedule, and partnerships with LITEON and Lessengers progress to prototype and early sampling stages. Operating cash burn remains controlled, and the U.S. redomiciliation is completed, attracting a broader base of institutional investors. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |